Published: 2019-12-25

Correlation of spirometry and six minute walk test in patients with chronic obstructive pulmonary disease from Sundargarh, Odisha, India

Yara Dinakar, Pradeep Panchadi Kiran, Akshaya K. Mohanty, Praveen Kishore Sahu, Anita Mohanty


Background: Six‑Minute Walk Test (6MWT) is a simple, objective, reproducible test which correlated well with different spirometric indices, and thus able to predict severity of Chronic Obstructive Pulmonary Disease (COPD) and can replace spirometry in resource poor set‑up. Here, author evaluated the correlation of 6 minute walk distance (6MWD) with spirometric indices in COPD patients and the potential of 6MWT as an alternative to the assessment of severity of COPD.

Methods: This cross-sectional observational study included a total of 80 COPD patients, diagnosed by GOLD criteria (Post bronchodilator FEV1/ FVC ratio <0.7). Modified Medical Research Council (mMRC) grading was used (age, weight, height, body mass index- BMI and breathlessness) and all the patients underwent spirometric measurement of FEV1, FVC and FEV1/ FVC ratio and tests were repeated after bronchodilation using 200-400 μg of salbutamol. 6MWT was performed following American Thoracic Society (ATS) protocol of 6MWT and distance was measured in meters.

Results: Author found significant negative correlation of 6MWT with age (r=-0.384, p=0.00) and mMRC grading of dyspnea (r=-0.559, p=0.00) and significant positive correlation with height (r=0.267, p=0.019) and weight (r=0.293, p=0.008). Significant positive correlation of 6MWD was noted with post bronchodilator FEV1(r=0.608, p=0.00), FEV1% (r=0.429, p=0.00), FVC (r=0.514 p=0.00), FVC% (r=0.313 p=0.005), FEV1/FVC % (r=0.336, p=0.001). Positive correlation was also observed between 6MWT and BMI but statistically insignificant (r=0.177, p=0.116). There was significant negative correlation between 6MWT and GOLD staging (r=-0.536, p=0.00).

Conclusions: This finding concludes that 6MWT can be used for the assessment of severity of disease in COPD patients in places where spirometry is not available.


Chronic obstructive pulmonary disease, Global initiative for chronic obstructive lung disease, Six-minute walk test, Spirometry

Full Text:



Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. 2017. Available at: Accessed 21 March 2017.

Gupta D, Agarwal R, Aggarwal AN, Maturu VN, Dhooria S, Prasad KT, et al. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India: offi Organ Ind Chest Soci. 2013;30(3):228.

Chen CZ, Ou CY, Wang WL, Lee CH, Lin CC, Chang HY, et al. Using post-bronchodilator FEV1 is better than pre-bronchodilator FEV1 in evaluation of COPD severity. COPD: J Chronic Obstruct Pulmonary Dis. 2012;9(3):276-80.

McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J. 1976;1(6013):822-3.

Wijkstra PJ, TenVergert EM, Van Der Mark T, Postma DS, Van Altena R, Kraan J, et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax. 1994;49(5):468-72.

Knox AJ, Morrison JF, Muers MF. Reproducibility of walking test results in chronic obstructive airways disease. Thorax. 1988;43(5):388-92.

ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med. 2002;166(1):111-7.

Ramanathan RP, Chandrasekaran B. Reference equations for 6-min walk test in healthy Indian subjects (25-80 years). Lung India: Offi Organ Ind Chest Soci. 2014;31(1):35.

Hong C, Liang BM, Tang YJ, XU ZB, Ke WA, Qun YI, et al. Relationship between 6-minute walk test and pulmonary function test in stable chronic obstructive pulmonary disease with different severities. Chinese Med J. 2012;125(17):3053-8.

Dogra AC, Gupta U, Sarkar M, Padam A, Chauhan A, Thakur S. Six-minute walk work in patients with chronic obstructive pulmonary disease. Int J Res Med Sci. 2014 Oct;2(4):1283.

Nagshin R, ZaKer MM, Etheshami AA. Association between Six-Minute Walk Test and Expiratory spirometry parameters in chronic obstructive pulmonary disease. Iranian Heart J. 2005; 6(3).

Kundu A, Maji A, Sarkar S, Saha K, Jash D, Maikap M. Correlation of six minute walk test with spirometric indices in chronic obstructive pulmonary disease patients: A tertiary care hospital experience. J Assoc Chest Phys. 2015 Jan 1;3(1):9.

Anil kumar K, Somanath D. Correlation between Forced Expiratory Volume in First Second (FEV1) And 6 Minute Walk Distance In Moderate, Severe and Very Severe Chronic Obstructive Pulmonary Disease. IOSR J Dental Med Sci. 2013; 5(2).

Khandelwal MK, Maheshwari VD, Garg S, Kumar K, Gupta R, Khandelwal S. Six minute walk distance: Correlation with spirometric & clinical parameters in chronic obstructive pulmonary disease. Int J Biomed Res. 2013 Apr;1(3):217-26.

Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, et al. The 6-min walk test: a quick measure of functional status in elderly adults. Chest. 2003;123:387-98.

Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14:270-4.

Poh H, Eastwood PR, Cecins NM, Ho KT, Jenkins SC. Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirol. 2006;11:211-6.

Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, et al. Six-minute walk test in children and adolescents. J Pediatr. 2007;150:395-9.